Sarepta Therapeutics (SRPT) Notes Payables (2014 - 2015)
Sarepta Therapeutics (SRPT) recorded quarterly Notes Payables of $2.5 million in Q4 2015, up 1.59% quarter-over-quarter from $2.5 million in Q3 2015, and little changed on a YoY basis from $2.5 million in Q4 2014.
Sarepta Therapeutics (SRPT) Notes Payables (2014 - 2015) Analysis & Trends
Sarepta Therapeutics' Notes Payables history runs 2 years deep, the most recent figure standing at $2.5 million for Q4 2015.
- In Q4 2015, Notes Payables changed 0.04% year-over-year to $2.5 million; the TTM figure through Dec 2015 stood at $2.5 million (changed 0.04% YoY), while the FY2015 annual figure was $2.5 million, changed 0.04% from the prior year.
- Notes Payables was $2.5 million for Q4 2015 at Sarepta Therapeutics, up from $2.5 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $4.9 million in Q2 2015 to a low of $2.4 million in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 2.49 Mn |
| Sep 30, 2015 | 2.45 Mn |
| Jun 30, 2015 | 4.91 Mn |
| Mar 31, 2015 | 4.83 Mn |
| Dec 31, 2014 | 2.49 Mn |
| Sep 30, 2014 | 2.42 Mn |